Vaxigrip Influenza Virus Vaccine Split Virion Suspension For Injection Kenya - angol - Pharmacy and Poisons Board

vaxigrip influenza virus vaccine split virion suspension for injection

sanofi pasteur s.a. 2 avenue pont pasteur 69007 lyon - influenza ah1n1 influenza ah3n2 and influenza b - suspension for injection - each 0.5 ml dose contains: influenza ah1n1...15… - viral vaccines: influenza vaccines

Fluenz Európai Unió - angol - EMA (European Medicines Agency)

fluenz

medimmune llc - reassortant influenza virus (live attenuated) of the following strains:a/california/7/2009 (h1n1)pdm09 like strain, a/victoria/361/2011 (h3n2) like strain, b/massachusetts/2/2012 like strain - influenza, human; immunization - vaccines - prophylaxis of influenza in individuals 24 months to less than 18 years of age.the use of fluenz should be based on official recommendations.

FLUMIST QUADRIVALENT Izrael - angol - Ministry of Health

flumist quadrivalent

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - nasal spray, suspension - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

vaxigrip tetra inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin 60 mcg 0.5 ml suspension

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; water for injections; potassium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate - vaxigrip tetra is indicated for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine for:,- active immunisation of adults, including pregnant women, and children from 6 months of age and older,- passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women (see sections 4.2 dose and method of administration, 4.4 special warnings and precautions for use, 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties ? clinical trials).

VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension for injection in pre-filled syringe needle free 2024 Season Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

vaxigrip tetra inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin 60 mcg 0.5 ml suspension for injection in pre-filled syringe needle free 2024 season

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; water for injections; potassium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate - vaxigrip tetra is indicated for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine for:,- active immunisation of adults, including pregnant women, and children from 6 months of age and older,- passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women (see sections 4.2 dose and method of administration, 4.4 special warnings and precautions for use, 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties ? clinical trials).

NOBILIS INFLUENZA H5N2 Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nobilis influenza h5n2

department of agriculture, fisheries and forestry - inactivated avian influenza virus type a, h5n2 - misc. vaccines or anti sera - inactivated avian influenza virus type a, h5n2 vaccine active 0.0 undefined - immunotherapy - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - avian influenza h5 | h5 | virus veterinary